| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Theravance Biopharma, Inc. (TBPH) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. TBPH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.65M | $27.37M | - | |
| VP | 355.3K | $5.89M | - | |
| CFO | 336.8K | $5.58M | - | |
| VP | 242.4K | $4.02M | -13,314 | |
| VP | 201.0K | $3.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 17, 2019 | O'Connor Donal | Director | Sell | 4,000 | $20.46 | $81,834.60 | -6.5% | |
| Mar 5, 2019 | Hegde Sharathchandra S | SVP, Research | Sell | 9,033 | $24.71 | $223,168.55 | -1.7% | |
| Sep 12, 2018 | Worboys Philip D | SVP, Translational Science | Sell | 6,393 | $28.50 | $182,200.50 | -3.7% | |
| Aug 27, 2018 | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sell | 7,119 | $27.71 | $197,281.73 | -7.8% | |
| Aug 15, 2018 | Gala Renee D | SVP, Chief Financial Officer | Sell | 43,743 | $26.79 | $1,171,791.02 | -7.3% | |
| Aug 8, 2018 | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sell | 31,300 | $27.94 | $874,575.12 | -8.2% | |
| Jun 8, 2018 | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sell | 14,040 | $23.97 | $336,527.49 | -5.1% | |
| May 21, 2018 | Malkiel Burton G | Director | Buy | 1,000 | $22.54 | $22,540.00 | +1.8% | |
| May 18, 2018 | Gala Renee D | SVP, Chief Financial Officer | Sell | 10,000 | $24.29 | $242,877.00 | -4.1% | |
| Sep 6, 2017 | Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sell | 14,670 | $30.77 | $451,350.42 | -9.8% |